Stock Details
LLY is Eli Lilly and Company's stock. Stock exchange NYSE (Currency USD). Average price in 50 days is 332.69$. Average daily volumn in 3 months 3.21M. Market cap 324.46B

Stock symbol : LLY. Exchange : NYSE. Currency : USD
Lastest price : 340.69$. Total volume : 2.03M. Market state POST
Click reload if you want to check the lastest price on market!!!

Eli Lilly and Company (LLY)
Last Price

Previous Close335.87
Day Range336.07-341.31
Bid0.00 x 1k
Ask0.00 x 1.1k
Average Volume3.21M
Market Cap324.46B
52 Week Range276.83-375.25
Trailing P/E49.23
Foward P/E29.09
Dividend (Yield %)1.35%
Ex-Dividend Date2023-02-14

Financial Details

According to Eli Lilly and Company's financial reports the company's revenue in 2022 were 28.54B an increase(0%) over the years 2021 revenue that were of 28.32B. In 2022 the company's total earnings were 6.24B while total earnings in 2021 were 5.58B( +20%).

Loading ...


Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer (NSCLC) and malignant pleural mesothelioma; Cyramz... a for metastatic gastric cancer, gastro-esophageal junction adenocarcinoma, metastatic NSCLC, metastatic colorectal cancer, and hepatocellular carcinoma; Erbitux for colorectal cancers, and various head and neck cancers; Retevmo for metastatic NSCLC, medullary thyroid cancer, and thyroid cancer; Tyvyt for relapsed or refractory classic Hodgkin's lymph and non-squamous NSCLC; and Verzenio for HR+, HER2- metastatic breast cancer, node positive, and early breast cancer. It offers Olumiant for rheumatoid arthritis; and Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis. The company offers Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Emgality for migraine prevention and episodic cluster headache; and Zyprexa for schizophrenia, bipolar I disorder, and bipolar maintenance. Its Bamlanivimab and etesevimab, and Bebtelovimab for COVID-19; Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. The company has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; AbCellera Biologics Inc.; Junshi Biosciences; Regor Therapeutics Group; Lycia Therapeutics, Inc.; Kumquat Biosciences Inc.; Entos Pharmaceuticals Inc.; and Foghorn Therapeutics Inc. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.


Market Cap:
Total Assets:
Total Cash:

News about "Eli Lilly and Company"

A Eli Lilly and Company (NYSE:LLY) insider increased their holdings by 1.4% last year

Source from : YAHOO!Finance - 1 days ago

From what we can see, insiders were net buyers in Eli Lilly and Company's ( NYSE:LLY ) during the past 12 months.See details»


Eli Lilly & Co. stock rises Tuesday, outperforms market

Source from : MarketWatch - 2 days ago

Eli Lilly & Co. closed $46.79 short of its 52-week high ($384.44), which the company achieved on January 24th. The stock outperformed some of its competitors Tuesday, as Johnson & Johnson JNJ fell ...See details»

Here is What to Know Beyond Why Eli Lilly and Company (LLY) is a Trending Stock

Source from : Nasdaq - 9 days ago

Eli Lilly (LLY) has recently been on ... Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate ...See details»

Eli Lilly and Company

Source from : Fortune - 8 days ago

ยฉ 2023 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and ...See details»

Eli Lilly to cut insulin prices, cap costs at $35 for many people with diabetes

Source from : CNN - 29 days ago

CEO of pharma giant on why the company is cutting cost of insulin (CNN)Eli Lilly announced Wednesday a series of price cuts that would lower the price of the most commonly used forms of its ...See details»

Eli Lilly and Company (LLY) Presents at Cowen's 43rd Annual Health Care Conference (Transcript)

Source from : Seeking Alpha - 23 days ago

[Call Starts Abruptly] at the Cowen Conference again this year. Representing the company is Mike Mason, who is President of Lilly Diabetes. So Mike, thank you for making the journey. Lots to cover ...See details»

Eli Lilly to cut insulin prices by 70%, cap monthly costs at $35

Source from : CBS News - 29 days ago

Eli Lilly plans to cut prices on its most commonly prescribed insulin products by 70% and will also cap customers' out-of-pocket costs at $35 a month for those with commercial insurance who use ...See details»

Drugmaker Eli Lilly caps the cost of insulin at $35 a month, bringing relief for millions

Source from : NBC News - 29 days ago

The cap applies to all of Eli Lillyโ€™s insulin products, said Kelly Smith, a spokesperson for the company. In addition to the cost caps, the company will lower the list price for several of its ...See details»

Eli Lilly cuts insulin prices up to 70% amid pressure to slash costs

Source from : ABC News - 29 days ago

The move follows criticism from federal lawmakers and advocacy groups. Eli Lilly will cut the price of its most commonly prescribed insulin products by 70% and expand a program that caps patient ...See details»


โ€˜Heroโ€™ journalist congratulated after Eli Lilly lowers price of insulin after his spoof tweet raised awareness

Source from : Yahoo - 28 days ago

He created an account with the handle @EliLillyAndCo โ€” the company's real handle is @LillyPad โ€” and issued a tweet saying the company planned to make insulin free. The fake tweet was so convincing ...See details»

Eli Lilly Alzheimer's treatment solanezumab failed to slow disease progression

Source from : CNBC - 21 days ago

Eli Lilly on Wednesday said it will halt development ... trial data on donanemab in the second quarter of this year. The company plans to ask the Food and Drug Administration to approve the ...See details»

Eli Lilly to cut insulin prices, as low as $25 a vial for most common drug

Source from : PBS - 29 days ago

Aside from Eli Lilly and the French drugmaker Sanofi, other insulin makers include the Danish pharmaceutical company Novo Nordisk. Neither company immediately responded to a request for comment ...See details»

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Axsome Therapeutics (AXSM)

Source from : Business Insider - 17 days ago

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Eli Lilly & Co (LLY โ€“ Research Report) ...See details»

After Years of Pressure, Eli Lilly Is Lowering the Price of Insulinโ€”Here's What You Need to Know

Source from : Yahoo News - 28 days ago

The pharmaceutical Eli Lilly and Company announced Wednesday that it will reduce some insulin prices by 70% and expand access to a program that caps prices at $35 per month. The company says its ...See details»